Market Closed -
Bombay S.E.
03:30:51 26/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
130.6
INR
|
-1.99%
|
|
-4.11%
|
-23.28%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,270
|
1,583
|
452.8
|
758.4
|
2,390
|
3,676
|
Enterprise Value (EV)
1 |
2,003
|
2,155
|
1,004
|
1,403
|
2,493
|
3,290
|
P/E ratio
|
15
x
|
6.89
x
|
4.4
x
|
-37.2
x
|
7.4
x
|
6.91
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.77
x
|
0.63
x
|
0.22
x
|
0.49
x
|
1
x
|
1.25
x
|
EV / Revenue
|
1.21
x
|
0.86
x
|
0.49
x
|
0.91
x
|
1.04
x
|
1.11
x
|
EV / EBITDA
|
9.78
x
|
5.14
x
|
4.32
x
|
31.2
x
|
4.49
x
|
3.95
x
|
EV / FCF
|
-18.9
x
|
18.5
x
|
-28.9
x
|
-14.5
x
|
5.44
x
|
7.99
x
|
FCF Yield
|
-5.3%
|
5.4%
|
-3.47%
|
-6.91%
|
18.4%
|
12.5%
|
Price to Book
|
2.42
x
|
2.1
x
|
0.53
x
|
0.9
x
|
2.06
x
|
2.17
x
|
Nbr of stocks (in thousands)
|
25,154
|
25,154
|
25,154
|
25,154
|
25,154
|
25,154
|
Reference price
2 |
50.50
|
62.95
|
18.00
|
30.15
|
95.00
|
146.2
|
Announcement Date
|
14/08/18
|
03/09/19
|
03/12/20
|
31/08/21
|
06/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,659
|
2,511
|
2,037
|
1,541
|
2,401
|
2,951
|
EBITDA
1 |
204.7
|
419.3
|
232.6
|
45
|
555
|
832.8
|
EBIT
1 |
163.7
|
368.5
|
173.6
|
-15.22
|
489.7
|
757.7
|
Operating Margin
|
9.87%
|
14.67%
|
8.52%
|
-0.99%
|
20.4%
|
25.68%
|
Earnings before Tax (EBT)
1 |
146.1
|
337.2
|
137.6
|
-23.91
|
465.2
|
747.1
|
Net income
1 |
84.72
|
229.9
|
103
|
-20.41
|
322.8
|
532.2
|
Net margin
|
5.11%
|
9.15%
|
5.06%
|
-1.32%
|
13.45%
|
18.04%
|
EPS
2 |
3.368
|
9.139
|
4.090
|
-0.8114
|
12.83
|
21.16
|
Free Cash Flow
1 |
-106.2
|
116.3
|
-34.78
|
-96.88
|
458.6
|
411.7
|
FCF margin
|
-6.4%
|
4.63%
|
-1.71%
|
-6.29%
|
19.1%
|
13.95%
|
FCF Conversion (EBITDA)
|
-
|
27.73%
|
-
|
-
|
82.63%
|
49.44%
|
FCF Conversion (Net income)
|
-
|
50.58%
|
-
|
-
|
142.05%
|
77.36%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/08/18
|
03/09/19
|
03/12/20
|
31/08/21
|
06/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
733
|
571
|
551
|
644
|
104
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
386
|
Leverage (Debt/EBITDA)
|
3.579
x
|
1.362
x
|
2.369
x
|
14.32
x
|
0.1868
x
|
-
|
Free Cash Flow
1 |
-106
|
116
|
-34.8
|
-96.9
|
459
|
412
|
ROE (net income / shareholders' equity)
|
17.5%
|
35.9%
|
12.8%
|
-2.41%
|
32.3%
|
37.3%
|
ROA (Net income/ Total Assets)
|
7.4%
|
14.5%
|
6.43%
|
-0.54%
|
16.1%
|
21.6%
|
Assets
1 |
1,145
|
1,581
|
1,602
|
3,766
|
2,003
|
2,460
|
Book Value Per Share
2 |
20.90
|
30.00
|
34.10
|
33.30
|
46.20
|
67.30
|
Cash Flow per Share
2 |
1.270
|
4.390
|
2.440
|
0.0800
|
8.390
|
0.0600
|
Capex
1 |
338
|
192
|
11.8
|
43.4
|
96.6
|
172
|
Capex / Sales
|
20.36%
|
7.65%
|
0.58%
|
2.82%
|
4.02%
|
5.84%
|
Announcement Date
|
14/08/18
|
03/09/19
|
03/12/20
|
31/08/21
|
06/09/22
|
04/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -23.28% | 40.19M | | +2.94% | 103B | | -11.86% | 59.25B | | +72.86% | 47.15B | | +11.16% | 37.09B | | +0.74% | 31.09B | | +4.74% | 18.82B | | +14.69% | 16.97B | | +9.34% | 13.67B | | -3.67% | 12.77B |
Other Commodity Chemicals
|